Abbott

Apr 02, 2020

In Brief This Week: Novacyt, Co-Diagnostics, Abbott, and More

News items for the in vitro diagnostics industry for the week of March 30, 2020.

Apr 01, 2020

Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

Bringing testing closer to patients could be helpful, provided enough tests and instruments can be manufactured and distributed.

Mar 27, 2020

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

The ID Now COVID-19 test is the second assay from the company to receive EUA from the FDA, following the same designation issued to the Abbott RealTime SARS CoV-2.

Mar 18, 2020

Abbott Garners Emergency Use Authorization for SARS-CoV-2 Test

The test will run on the m2000 RealTime molecular system, and the company said it will be shipping 150,000 tests immediately.

Mar 16, 2020

Biotin Interference Still an Albatross For Labs, Diagnostics Developers

Premium

Labs are using specific protocols to mitigate the effects of biotin, a vitamin supplement that can interfere with test results.

Mar 09, 2020

FDA Grants 510(k) Clearances to Roche Diagnostics, Abbott, Siemens Healthineers, Others in February

Abbott received five separate clearances associated with its i-Stat Chem8+ cartridge running on the company's iStat 1 system.

Mar 05, 2020

Ferris State Team Looking to Expand Scope of Pharmacy-Based Lab Testing

Premium

The researchers are studying use of pharmacy testing to monitor hypertension and cholesterol as well as for detecting and managing various infectious diseases.

Feb 13, 2020

POC Molecular Flu Tests Finding Resistance in Pediatrics Despite High Accuracy

Premium

A recent study established high sensitivity and specificity for three CLIA waived point-of-care molecular flu tests in pediatric samples.

Jan 22, 2020

Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

Abbott said the increase in diagnostics revenue was driven by adoption of the company's Alinity family of diagnostic instruments.

Jan 17, 2020

Abbott Warns Customers to Discontinue Use of Certain Blood Analysis Cartridges

The company reported performance changes that led to the product recall and said it is pursuing eventual FDA clearance for the devices.

Menu

Abbott

In Brief This Week: Novacyt, Co-Diagnostics, Abbott, and More

Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

Abbott Garners Emergency Use Authorization for SARS-CoV-2 Test

Biotin Interference Still an Albatross For Labs, Diagnostics Developers

FDA Grants 510(k) Clearances to Roche Diagnostics, Abbott, Siemens Healthineers, Others in February

Ferris State Team Looking to Expand Scope of Pharmacy-Based Lab Testing

POC Molecular Flu Tests Finding Resistance in Pediatrics Despite High Accuracy

Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

Abbott Warns Customers to Discontinue Use of Certain Blood Analysis Cartridges

Pages

Breaking News

With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

Beroni Receives CE Mark for SARS-CoV-2 IgG/IgM Antibody Detection Kit

LetsGetChecked Targets Front-Line Healthcare Workers With New, Two Part SARS-CoV-2 Test

LexaGene Shifts Gears to Prepare Viral RT-qPCR Panel for FDA Emergency Submission

Oxford Immunotec Preliminary Q1 Revenues at High End of Guidance, Firm Withdraws Full-Year Guidance

Philips, Leica Biosystems Receive Remote Digital Pathology FDA Waivers During Coronavirus Pandemic

What's Popular?

Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

In Brief This Week: Novacyt, Co-Diagnostics, Abbott, and More

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

Sponsorships